483
Eric Wolfson, D.O.FDA 483 - Eric Wolfson, D.O. - August 09, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Eric Wolfson, D.O. in Las Vegas, NV, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to follow the signed statement of investigator, enrollment of ineligible subjects, unperformed study procedures, and missing critical study documentation. Additionally, investigational drug disposition records were found to be inadequate, lacking proper accountability and reconciliation.
Open in Dashboard
ID · 88c79c79-9c4c-425e-969a-eb2e5b1b9ad7